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Worldwide, head and neck malignancies are the eighth most frequent cause 
of cancer mortality, and comprises about 8-10% of all cancers.1 Cancer is a 
pathological condition in which uncontrollable growth of cells invade and start 
damaging surrounding tissue. These cells are called malignant or cancerous 
cells. Oral cancer or mouth cancer mainly occurs on the lower lip, inside 
the mouth, on salivary glands, tonsils, on the back of the throat, on the area 
behind the third molars (retromolar trigone), esophagus, and on the tongue 
and soft tissues of the mouth.2 According to the National Institute of Dental 
Craniofacial Research (NIDCR), it accounts for around 3% of all malignancies 
or cancers diagnosed yearly in the United States. Cancer Research UK reported 
7800 new cases each year of mouth and oropharyngeal cancer. The statistics 
regarding mouth cancer incidence is alarming for the next generation, so early 
diagnosis by a non-invasive approach is useful for controlling it. Recognition 
of oral squamous cell carcinoma (OSCC) presently relies on skilled clinical 
investigation and histological study of suspicious areas, but at sites not easily 
visibly, it might be go by unnoticeable.2 Consequently, precise and sensitive 
biomarkers for oral squamous cell carcinoma might be supportive in early 
diagnosis of high-risk patients.3
Human oral fluid consists mainly of saliva produced by the salivary 
glands, gingival crevicular fluid (GCF), secretions from labial mucosal glands 
and oropharyngeal glands secretions.4-6 The main component of oral fluid 
is saliva, and it contains much-hidden information of the human health 
status. Previously our group reported on the importance of human saliva 
as a diagnostic fluid and how to do the sampling and extraction of salivary 
proteins.7,8 The value of saliva as a means for detection of oral malignancies 
has been increasing in parallel with recent diagnostic technological advances.6 
Both saliva and blood are the most widely considered body fluids and may 
provide definitive biomarkers for early cancer detection.5 Employing saliva is 
a non-invasive and cost-effective technique compared to serum analysis and 
is a useful body fluid comprising a collection of components (DNA, mRNA, 
protein) which are used as biomarkers for translation, clinical applications, 
western blot assays, enzyme-linked fluorescence assays and polymerase chain 
reaction.9-11 Whole saliva can be collected non-invasively, by the patients 
themselves with no specialized technique with no requirements of specialized 
apparatus, and it is also favorable for use in children as it is associated with a 
higher acceptance rate. Salivary detection tools are of utmost significance as  it 
helps in screening, early detection of high-risk groups, patients with previous 
cancer history as well as patients with pre-malignant lesions and it might 
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be used to assess  the effectiveness of cancer treatement.12 
Saliva investigation for early recognition of oral cancers also 
has the considerable advantage that this fluid contains shed 
desquamated cells of the oral cavity, making it as a first choice 
for the screening and recognition of biomarkers. Circulatory 
markers and salivary tumor markers have been studied in 
multiple studies of oral squamous cell carcinoma that reported 
specific and sensitive results regarding the prognosis and early 
diagnosis.2,13 Similarly, in oral squamous cell carcinoma 
studies, salivary defensin-1 levels were found to be increased, 
and a significant association was noticed between serum 
levels of squamous cell carcinoma antigens and salivary 
defensin-1.14,15 When compared with healthy individuals, 
raised levels of salivary nitrite and nitrate in oral cancer 
patients, as well as increased activity of nitrate reductase, were 
noticed and reported in multiple studies.16 Fliss et al., reported 
that mitochondrial DNA mutations are useful to distinguish 
the exfoliated oral squamous cell carcinoma cells in saliva. 
By direct sequencing of saliva samples from OSCC patients, 
mutations were identified in 67% of those samples.17 St John 
et al.,18 reported that IL-8 and IL-6 can be useful biomarkers 
in the saliva of OSCC patients.
 Increased IL-8 levels have an essential role in chemotaxis 
of granulocytes and macrophages and stimulation and 
proliferation of angiogenesis, which are a well-known part of 
OSCC stroma; similarly, raised IL-6 levels lead to immune 
unresponsiveness and initiation of cachexia, hypercalcemia 
and wasting; both IL-8 and IL-6 levels have been found to be 
increased above the cutoff values.18,19 This diagnostic fluid can 
be beneficial for the future of point-of-care (POC) technology 
and sensor development for low-cost diagnosis.20  
Thus, in conclusion, saliva sampling and its screening is a 
good choice for the early detection and screening of high risks 
patients for oral squamous cell carcinoma (OSCC). It is a non-
invasive as well as cost-effective technique. Large-scale studies 
are still needed to check the sensitivity and specificity of the 
saliva for detection of OSCC. The advancements in salivary 
fluid sampling devices and -omics science is helping researchers 
to do more in-depth studies and explore as of yet unidentified 
biomarkers. The whole paradigm is to revolutionize point-of-
care (POC) and biosensor technology is for the betterment of 
humanity.  
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